BRD4 and medulloblastoma: Although the BRD4 level did not stratify patient survival in the total medulloblastoma cohort (Supplementary Fig. S4A), a lower BRD4 expression level was associated with significantly better survival in the SHH medulloblastoma subgroup (Fig. 3G).